Welcome to the 202nd Pari Passu newsletter.
In today’s edition, we’re covering Pretium Packaging, one of the largest rigid plastic packaging manufacturers in North America. Acquired by Clearlake Capital in January 2020, Pretium was transformed in under two years. Soon after closing, Clearlake completed a dividend recapitalization and nearly doubled the platform through the 2021 acquisition of Alpha Packaging, leaving Pretium with roughly $1.6bn of debt.
Within a year, the assumptions beneath that structure, durable post-pandemic demand and low interest rates, had broken. Customer destocking cut revenue roughly 18% from its peak, a troubled Alpha integration turned part of the decline into lost market share, and rising rates nearly doubled the company’s interest bill. In October 2023, Pretium executed a consensual uptier that raised $325mm of new money from its existing first lien lenders. The LME solved the liquidity problem but left a larger, costlier stack behind. Pretium spent much of its new runway repurchasing second lien debt at a discount rather than repairing the business, and when demand softened again in 2025, the cash ran out. In January 2026, the company filed a prepackaged Chapter 11.
In this write-up, we’ll walk through Pretium’s business model, trace the corporate history from Clearlake’s 2020 buyout through the Alpha acquisition, then break down the path to distress and the 2023 LME. We’ll close by examining the events that led back to distress, the 2026 Chapter 11, and Pretium’s outlook from its second fresh start.
Part of a firm that might benefit from a group subscription and full access to our Research and Data? Learn more and email us at: [email protected]
Before we get started, we are releasing our training programs on restructuring and special situations investing in the next few weeks. To be notified when they are released, register here.

AI is driving one of the largest capital allocation cycles the credit market has seen.
But the opportunity is creating new risks across software, infrastructure and private credit — from hidden lease commitments and data center financing to changing SaaS economics and portfolio exposure.
9fin’s new whitepaper explores:
Capital allocation into AI credits
Risks of massive AI commitments
How AI is sorting the credit universe
New economics of SaaS businesses in the world of AI
Private credit’s AI explosion and implosion
Built using 9fin’s proprietary data, market expertise alongside 9fin AI Chat, it shows what’s possible when deep credit intelligence and purpose-built AI work together.
Business Model
Before getting into Pretium’s history, it’s worth understanding what the company does. At its core, Pretium is a plastics molding business. Its process is summarized by designing a container, building or buying the steel mold that gives that container its shape, then melting raw plastic pellets called resin, and injecting the liquid plastic into the mold. This process is used to produce rigid plastic bottles, jars, canisters, and caps. Pretium then designs and sells to the consumer brands that fill them: think of the bottle your multivitamins come in or the jug of cleaning solution under your sink. Today, Pretium is one of the largest rigid packaging manufacturers in North America, and generated ~$735mm of revenue in 2025 from 24 automated plants across the United States, Canada, Mexico, Ireland, and the Netherlands with roughly 3,100 employees [1][2].
Rigid plastic packaging is an enormous but fragmented market, and Pretium occupies a deliberate niche. Giants such as Graham Packaging, Plastipak, Berry, and Amcor serve the mass market with high-cavitation machines, machines that are built to churn out millions of identical units per cycle. These machines are most economical on long, dedicated runs for a single product, so they generally avoid switching a line from one product to another. Unlike these packaging giants, Pretium specializes in short- to medium-run production for private label and emerging brands, competing more against independently owned regional molders [3]. These small minimum order quantities command premium pricing, which is why Pretium has historically posted EBITDA margins around 20%, versus the mid-teens typical of larger packaging peers [3].
The company sells two types of solutions, custom and stock. With custom solutions, Pretium designs a container for a specific customer. If the design is exclusive to one brand, the customer pays for and owns the steel mold. If Pretium instead designs around a broader market trend, it keeps the mold and can sell the container to anyone. With stock solutions, Pretium holds a catalog of thousands of ready-made containers in inventory and owns every mold. Across both solutions, the company maintains more than 3,000 active molds [1]. This ownership matters because molds are expensive: as we covered in our MRP Solutions write-up, a single complex mold can cost $50,000 to $500,000, and that bill normally lands on the customer who wants the container made. Since Pretium owns a vast, long-since-paid-off mold library, a new customer can start ordering without funding a mold upfront, so Pretium can serve everyone from a two-person startup to a multinational consumer packaged goods (CPG) company like Procter & Gamble [4]. This ownership creates a self-reinforcing customer pipeline. Small brands typically buy Pretium’s stock containers through distributors, middlemen that bundle packaging from many suppliers for brands too small to buy direct. When a small brand is acquired by a large CPG, the new owner has the scale to cut out the middleman and buy direct, and it comes to Pretium, because Pretium owns the only molds that make the container [4].

Figure 1: Pretium develops both custom and stock solutions for companies
Plastic resin is Pretium’s highest cost. Nearly all of its business sits under contracts that pass resin price changes through to customers every one to two months, largely protecting margins when plastic prices swing [3]. Pretium also makes containers from up to 100% recycled plastic, winning business from brands promising consumers more sustainable packaging [5]. Its plants are heavily automated. Across more than 60% of Pretium’s production lines, robotic arms handle the repetitive end-of-line work of pulling molded parts off the machine, packing them into cases, and stacking those cases onto pallets. This cuts the labor needed to run a line and has produced measurable cost savings, an advantage we return to shortly [1].
Pretium sells into five end markets. Food and specialty beverage is the largest at roughly 31% of 2020 sales, supplying condiment bottles, snack containers, and spice jars [1][3]. Since people buy groceries in good times and bad, this is a recession-resilient anchor. Nutrition and wellness, containers for vitamins, supplements, and protein powders, was just 12% of sales in 2020 but has since grown into the platform’s most profitable segment, driven, as a former Pretium operations executive explained to us, by the small, high-changeover production runs these brands require, a shift we will later unpack [4]. Household and commercial chemical (28%) supplies sturdy, chemical-resistant jugs for cleaning products, another steady-demand segment. Healthcare (15%) covers medical and prescription containers, where strict regulatory approvals make customers reluctant to switch suppliers. Personal care and beauty (13%) rounds out the mix with cosmetics bottles, the segment most exposed to discretionary spending [3]. Notably, no single customer dominates: the top ten account for roughly 32% of sales, and the largest just 6% [3].
The weakness in this model is volume. Pass-through contracts protect Pretium when plastic prices rise, but nothing protects it when demand falls, and customers order fewer containers. The automated plants cut both ways. They lower the labor a busy line needs, but trade that labor for machinery Pretium pays for whether the line runs or not. When volumes fall, those fixed costs spread across fewer units, and margins compress quickly. Demand is not as safe as the grocery-heavy mix suggests: wellness and beauty are among the first purchases consumers cut, and some products, like protein powder, can switch from rigid containers to cheap flexible pouches altogether [4].
More fundamentally, the premium Pretium earns comes from how it serves, not from what it sells. The container itself is a commodity, and most customers have several molders approved to make the same part, so orders follow price, spare capacity, and freight distance [4]. That leaves little to hold an account in place when a nearer competitor quotes lower, and market share lost this way has to be won back the same way.
Corporate History
Now that we’ve covered the business, let’s look into how it evolved over time. Pretium’s roots trace back to 1992, when the company was founded in St. Louis, Missouri, as a regional maker of specialty plastic containers. Over its first two decades, Pretium grew slowly, adding plants and customers one at a time. The transformation into a national platform came in 2014, when the company was bought out by Genstar Capital, a San Francisco-based middle-market private equity firm, alongside Ares Management [6].
Although deal terms were not disclosed, we know that under Genstar’s ownership, Pretium completed seven add-on acquisitions in six years: Tri-Delta Plastics (2014), Intertech (2015), Custom Blow Molding (2016), Patrick Products (2017), Cox Container (2018), and Olcott Plastics and Starplex Scientific (both 2019) [3][7]. Each deal bolted on a new end-market specialty. The most consequential was Custom Blow Molding, which made Pretium the leading North American producer of jars and canisters made from high-density polyethylene (HDPE), the sturdy, opaque plastic used for protein powder tubs, for sports nutrition brands, expanding the nutrition and wellness segment we flagged in the company’s business model [5]. By 2019, Pretium was generating $398mm of revenue from 19 plants, 17 in the US and two in Canada, up from $333mm two years earlier [3]. However, the buildout was not cheap. As the company continued to grow, it also burned cash every year from 2017 through 2019 and carried leverage above 8.0x. In January 2020, Genstar and Ares sold Pretium to Clearlake Capital.
Clearlake’s thesis on buying Pretium centered on the company’s innovative and sustainable packaging solutions, national scale, and automation [8]. Neither the purchase price nor the buyout financing was ever disclosed, since the buyout was financed with private credit, but comparable packaging M&A of the era priced in the high single digits, from Berry Global’s 2019 acquisition of RPC Group and Silgan’s 2020 purchase of Albéa’s dispensing business [9][10]. Applying 8x to 9x, we estimate an enterprise value in the $850mm to $950mm range. At the time, Pretium was generating $474mm of revenue at a 22% EBITDA margin, implying roughly $104mm of EBITDA [3].
Clearlake wasted no time monetizing its new platform. In October 2020, just nine months after closing, Pretium launched a dividend recapitalization, refinancing the private credit facilities from the buyout and funding a distribution to Clearlake. Although the exact dividend was never disclosed, the recap put in place a $540mm first lien term loan due November 2027, a $160mm second lien term loan due 2028, and an undrawn $60mm ABL revolver, bringing leverage to 6.7x [3][11].

Figure 2: 2020 Dividend Recap Table
The deal that defined Clearlake’s ownership came in late 2021. In September, Pretium announced the acquisition of Alpha Packaging, a fellow St. Louis-based rigid packaging manufacturer with nine plants across the US and Europe and a market-leading portfolio of PET vitamin and gummy containers [1]. The deal nearly doubled Pretium. Combined revenue reached $885mm in 2022, nearly double Pretium’s roughly $500mm standalone base the year before [12][13]. The plant count rose from 19 to 28, and the combined company would generate two-thirds of sales from the growing wellness, specialty food and beverage, and personal care segments [12]. Three months later, in December 2021, Pretium bolted on Grupo Edid, a family-owned manufacturer, giving the company its first footprint in Mexico [14].
To fund Alpha, Pretium refinanced its entire capital structure on October 1st, 2021. The new stack replaced the $700mm structure outright and consisted of a $100mm ABL revolver due October 2026, a ~$1.3bn first lien term loan due October 2028, and a $350mm second lien term loan due October 2029 [15].

Figure 3: Post-Alpha Acquisition Cap Table
Let’s consider what Clearlake had built in under two years. Two forces had driven Pretium’s growth. The first was the Alpha acquisition itself, which nearly doubled the platform’s plant count and pushed it into the fast-growing wellness and specialty food segments. The second was the pandemic, which sent demand surging as consumers stockpiled the vitamins, supplements, and cleaning products Pretium’s containers hold. Together, they carried revenue from $474mm at Clearlake’s purchase to $885mm by 2022. Funded debt rose alongside it, from $700mm to roughly $1.6bn. However, the new debt was priced when SOFR sat near zero, and Clearlake had already pulled a dividend out of the business. The feasibility of the leverage rested on two assumptions: that the recent acceleration in demand would hold and that interest rates would stay low. Within a year, both broke.
Path to Distress
Over the following 18 months, three forces would ultimately drain the company’s liquidity. First, customer demand reversed as over-ordering from the pandemic unwound. Second, the Alpha integration disrupted the business it was meant to grow. Third, rising rates pushed the company’s interest expense past what the company’s operations could cover.
Customer Destocking
The first signs of distress came following the COVID-19 pandemic. As we mentioned, during the pandemic Pretium’s end markets, particularly nutrition and wellness, experienced a surge in demand as consumers stockpiled vitamins, supplements, and cleaning products. However, Pretium’s customers over-ordered containers to protect themselves against strained supply chains, building inventory well beyond normal levels. In 2022, this dynamic reversed. As consumption normalized, customers worked down the containers already sitting in their warehouses rather than placing new orders, and Pretium’s revenue fell from a peak of $885mm in 2022 to roughly $730mm in 2023, a ~18% decline [16]. Unit volumes fell further still, since resin pass-throughs supported pricing even as order counts dropped. As we covered in the Business Model section, Pretium’s costs are largely fixed. The company still paid for its 24 plants, its mold library, and its automated lines whether they ran or not, so lower utilization translated directly into margin compression. The decline was steepest in nutrition and wellness, the segment the Alpha acquisition had been meant to expand [4]. Beyond destocking, protein powder brands began shifting from rigid canisters to cheaper flexible pouches, a structural substitution that pulled volume out of Pretium’s most profitable plants, as the former operations executive we spoke with explained. The clearest example was Vital Proteins, a collagen powder brand for which Pretium had invested in dedicated capacity against a contracted annual volume. When the brand’s volumes fell away, both the capacity and the capital spent building it sat stranded [4].
Failed Alpha Integration
The customer destocking arrived while Pretium was still integrating Alpha, which created problems of its own. Alpha had operated a centralized customer service model, where a customer with orders across several Alpha plants dealt with a single representative in St. Louis, who scheduled production across the network on the customer’s behalf. Pretium ran the opposite model, in which each plant handled its own accounts. When Pretium moved Alpha’s customers onto its model, an account that once made one call now dealt with a different team at every plant that made its containers, and service levels suffered during the transition [4]. Following this, several of Alpha’s commercial leaders departed, taking with them the relationships behind Alpha’s distributor channel. Distributors, which depended on the high-touch service Alpha had built, responded by moving volume to competing molders, and those competitors targeted Pretium’s accounts aggressively throughout the period [4]. Some of the volume lost in 2022 and 2023 was therefore not just destocking, but also market share that would have to be won back account by account.
Rise in Interest Rates
These strains on the company’s earnings were further compounded by a rise in interest rates. As a reminder, the October 2021 refinancing left Pretium with roughly $1.3bn of first lien term loans priced at S + 4.00% and $350mm of second lien term loans at S + 6.75%, each with a 0.50% floor. When the structure was put in place, SOFR sat near zero, and the company carried ~$85mm in annual interest expense. By mid-2023, SOFR exceeded 5%, and we estimate Pretium’s interest expense nearly doubled to approximately $165mm, with the first lien now costing around 9% and the second lien around 12%. At the 2020 recap’s pricing, with LIBOR near zero, the $700mm structure had carried roughly $36mm of annual interest, we estimate. Debt had since grown two and a half times, but the interest bill nearly fivefold. Against the company’s $190mm adjusted EBITDA, interest now consumed nearly 90 cents of every dollar the business was generating [15].

Figure 4: 2023 Interest Build
In response to these pressures, management concentrated on the variables within its control. Automation, by then deployed across more than 60% of production lines, was already generating measurable cost savings [15]. The company closed its Ypsilanti, Michigan plant, discontinued low-volume products, and relocated its better molds to fuller facilities, which lifted utilization at the plants that remained. At the same time, it worked to repair the distributor relationships damaged in the Alpha integration, slowing the loss of accounts [4]. While these programs were designed to save tens of millions over several years, Pretium’s interest expense outpaced those savings well before the lost EBITDA from falling volumes was even counted. Because the gap was too large for operational fixes to close, it showed up as a liquidity problem. Pretium covered the deficit by drawing on a revolver, which by mid-2023 had grown to roughly $65mm while cash had fallen to roughly $10mm, leaving total liquidity of roughly $45mm. With earnings barely covering interest, free cash flow turned negative after accounting for debt amortization, taxes, working capital, and capex [17].
With no cushion left, Pretium needed fresh cash to carry it through this stretch, and the conventional sources of it were unavailable. The remaining revolver capacity could not bridge a deficit of this size, and Clearlake, having already taken a dividend out of the business, had little incentive to contribute equity beneath $1.7bn of debt. The only remaining source of capital was Pretium’s existing lenders.

Figure 5: Pre-LME Capital Structure
2023 LME
On October 2nd, 2023, Pretium announced it had reached agreement with a majority of its first lien lenders on a transaction that would raise $325mm of new capital and restructure its first lien debt into a new tiered structure. The company was advised by Kirkland & Ellis and Evercore, and the ad hoc group of first lien lenders by Davis Polk [1][18].
The structure was not the only option considered.
You are about to reach the midpoint of the report. This is where the story gets interesting.
Free readers miss out on the sections that explain:
• Breakdown of 2023 LME (with detailed economics)
• 2023 LME analysis and the key basket left open
• Operational events leading to 2026 distress
• The 100-name DQ List and discounted 2L buybacks
• 2026 Chapter 11 and the high exit LTV
• Outlook & Key Lessons with focus on MRP restructuring
Upgrade to Pari Passu Premium to access the remainder of this deep-dive, the full archive with over 150 editions, and our restructuring drive.
Professionals accessing Pari Passu in connection with their work at a financial institution, investment firm, law firm, consulting firm, or any other commercial enterprise are required to upgrade to the Research Tier.
All subscriptions are licensed for a single user. No subscription, at any tier, may be shared, forwarded, or made accessible to other employees, colleagues, or a shared/group inbox. Firms with multiple users must obtain a group subscription. To set up group access for your team, please contact [email protected]
Our LME Tracker is reserved for group subscriptions
Unlock the Full Analysis and Proprietary Insights
A Pari Passu Premium subscription provides unrestricted access to this report and our comprehensive library of institutional-grade research
Upgrade NowA subscription gets you:
- Institutional Level Coverage of Restructuring Deals
- Full Access to Our Entire Archive
- 150+ Reports of Evergreen Research
- Full Access to All New Research
- Access to the Restructuring Drive
- Join Thousands of Professional Readers

